{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:43:21Z","timestamp":1760028201316},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/hpc.0000000000000017","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T05:53:10Z","timestamp":1406267590000},"page":"109-113","source":"Crossref","is-referenced-by-count":7,"title":["A Standardized Bleeding Risk Score Aligns Anticoagulation Choices with Current Evidence"],"prefix":"10.1097","volume":"13","author":[{"given":"Arielle S.","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy S.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"R2-6-20210126","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"R3-6-20210126","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"R4-6-20210126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1753944708093847","article-title":"Stroke prevention: modifying risk factors.","volume":"2","author":"Romero","year":"2008","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R6-6-20210126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archinte.164.1.55","article-title":"National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.","volume":"164","author":"Fang","year":"2004","journal-title":"Arch Intern Med"},{"key":"R8-6-20210126","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"R9-6-20210126","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1538-7836.2011.04378.x","article-title":"Bleeding risk in real world patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.","volume":"9","author":"Olesen","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R10-6-20210126","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1378\/chest.12-0608","article-title":"Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a real-world population with atrial fibrillation receiving anticoagulant therapy.","volume":"143","author":"Roldan","year":"2013","journal-title":"Chest"},{"key":"R11-6-20210126","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"R12-6-20210126","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation.","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"R13-6-20210126","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"R14-6-20210126","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2012.10.010","article-title":"Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients.","volume":"61","author":"Apostolakis","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R17-6-20210126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0163278707307899","article-title":"Methodologies for improving response rates in surveys of physicians: a systematic review.","volume":"30","author":"VanGeest","year":"2007","journal-title":"Eval Health Prof"},{"key":"R18-6-20210126","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/CIRCULATIONAHA.112.115410","article-title":"Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.","volume":"126","author":"Dentali","year":"2012","journal-title":"Circulation"},{"key":"R19-6-20210126","doi-asserted-by":"crossref","first-page":"e33559","DOI":"10.1371\/journal.pone.0033559","article-title":"Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.","volume":"7","author":"Konrat","year":"2012","journal-title":"PLoS One"},{"key":"R20-6-20210126","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:40:18Z","timestamp":1620952818000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00132577-201409000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000017","relation":{},"ISSN":["1535-282X"],"issn-type":[{"value":"1535-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}